The phrase "alteration of peptide" is correct and usable in written English.
It can be used in scientific or medical contexts when discussing changes or modifications made to peptides, which are short chains of amino acids.
Example: "The alteration of peptide sequences can significantly impact their biological activity and function."
Alternatives: "modification of peptide" or "change in peptide".
Nevertheless, the production of small, single epitope is challenging of stability issues and possible alteration of peptide structure.
In some cases, a functional linker is introduced between dye and peptide to minimize the alteration of peptide biological activity.
Notably the latter group involves a chemical alteration of peptide samples during a labeling step in order to incorporate an isotope-encoded tag.
Comparison of amino acid residues between HLA-B*1301 HLA-B*13011302 showed thandonly HLA-B*1302 HLA-B*1302ompared with TWT) were different, and reshowed95 is a major componenthat ponlythreeBy generesiduesecombIIRnt HLA-B molecomparedd studying the eluted peptides by mass spectrometry and pool sequencing, Bade-Doeding et al. (2007) found that residue 95 causes strong alteration of peptide motifs.
Some of the changes involve the alteration of the peptide charge.
This group of motifs is involved in the catalyzed conformational alteration of a peptide backbone.
The design process of peptidomimetics usually involves an initial major alteration of the peptide backbone, thereby resulting in class A, B, or C mimetics.
In addition, it may result from the subversion of cell physiology as a consequence of the overexpression of oncogene-coded proteins [ 26, 27], and alteration of antigenic peptide-processing machinery [ 28, 29].
To improve the stability of the wild-type scFv molecule by alteration of the linker peptide, this region was randomised by PCR and the resulting scFv fragments were recloned into a phagemid vector for display on phage.
Alteration in the process of peptide production by the CVLP SNP could have important implications in the expression or maintenance of MHC class I molecules on the cell surface and be linked to the pathogenesis of the disease.
However, this drug could also be proposed for the treatment of those syndromes inducing obesity characterized by genetic alterations of hypothalamic peptides signaling systems.
